Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nasal Dexmedetomidine vs Oral Pentobarbital for Sedation in Pediatric TTE
NCT02250820Phase 1Completed
- Sponsor
- Cincinnati Children's Hospital Medical Center
- Start
- Nov 2014
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of dexmedetomidine in Procedural sedation (PS) (2 arms), sponsored by Cincinnati Children's Hospital Medical Center. Primary endpoint: Sedation Quality at 60 minutes. Started Nov 2014; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
Procedural sedation (PS)
Beyond the preview
Go deeper on NCT02250820.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02250820.